Thursday 13th November
Introduction to regulatory guidance
· Assessing and understanding the relevant ICH guidance: Q8, Q9, Q10, Q11, Q12, Q13, Q14 EMA and FDA process validation related guidance
· Gain an understanding of the rationale behind the requirements
· Overview of other relevant guidance
Quality by Design (QbD) Concept and Approaches & Exercises on TPP, QTPP, CQAs, CMAs, CPPs
· Gain a practical guidance to QbD
· How to apply QbD
· Practical considerations of applying a QbD approach
Risk assessment methodologies & practical considerations
· Fields of application
· Different risk management methods and tools - Examples for Failure Mode, Effect and Criticality Analyses (FMECA)
· Learn how to assess and manage risks
Stages in Development 1, 2 and 3
· Examining design, qualification and validation
· Discover what to do and when
· Defining the process and ranges
Control strategy development and implementation
· Overview and examples of process controls
· Importance of analytical method
· Developing a process control strategy including ranges
· Control charts data analyses
· Examining the process and identifying critical process parameters
· Process parameter categorization & how to validate
Process Performance Qualification
· Prerequisites
· How to perform a process performance validation
· Studies to be included
· Protocol & report requirements
· Continue process verification and validation
Conclusions and Feedback
- Margit Holzer - Scientific Director, Ulysse Consult
- Thomas Chattaway - Senior Life Science Consultant, Self-Employed
- Chromatography Fundamentals for Biologics Process Development - Day 1
- Chromatography Fundamentals for Biologics Process Development - Day 2
- Wednesday 5th November 2025
- Thursday 6th November 2025
- Tech Transfer for Biopharmaceutical Manufacturing - Day 3
- CMC Roadmap - Day 1
- Thursday 13th November
- Bioprocess Characterisation, Qualification and Validation - Day 2
